All filters
Videos
HIV cure and eradication | Ricardo Diaz, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
Present and future of ART in Latin America | Carlos Beltrán, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
Do we really need new drugs? | Mark Nelson, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
The aging HIV infected patient - neurological issues - poly pharmacy | Ernesto Martinez Buitrago, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
HIV in Women - PTMCT - pregnancy | Isabel Cassetti, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
Strategies for hepatitis C elimination | Francesca Ceccherini– Silberstein, PhD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
Implementation of DAAs in clinical management | Mark Nelson, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
Local situation in LA (epidemiology / treatment options) | Jorge Contreras, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
Early diagnosis & testing | Susana Cabrera, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
Clinical Implications of low level viremia/ failure and resistance | Francesca Ceccherini– Silberstein, PhD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
Difficult to reach populations in Latin America | Ana Paulina Celi de la Torre, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
WHO Target 90-90-90 : Achievable for Latin America | Alejandro Afani, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Videos
HIV in Latin America: 35 years later | Marcelo Wolff, MD, FACP, FIDSA
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
WHO Target 90-90-90 : Achievable for Latin America- Alejandro Afani, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
HIV in Latin America: 35 years later- Marcelo Wolff, MD, FACP, FIDSA
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
Difficult to reach populations in Latin America- Ana Paulina Celi de la Torre, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
New approaches for preventing transmission- Charles Boucher, MD, PhD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
State-of-the-art lecture on PrEP- Mauro Schechter, MD, PhD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
Proviral DNA as a Target for HIV-1 Resistance Analysis- Dr. Lara
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
Transmitted Drug Resistance in HIV-Infected Treatment-Naïve Patients in Chile between 2014 and 2017- Dr. Palma
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
Clinical Implications of low level viremia/ failure and resistance- Francesca Ceccherini– Silberstein, PhD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
Risk profiles for HIV transmission and HIV status in MSM versus heterosexual men populations in the South West of Colombia - Dr. Mueses-Marín
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
Moving forward to 90-90-90: Analysis of a cohort of recently-diagnosed patients in a tertiary hospital in Buenos Aires, Argentina - Dr. Barletta
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
Early diagnosis & testing- Susana Cabrera, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017